Kisspeptin-10
Kick-starts your body's own testosterone production at the very top. It sits upstream of the entire HPG axis, triggering the natural cascade of GnRH → LH → testosterone, a different lever than the melanocortin libido peptides.
Kisspeptin-10: Kick-starts your body's own testosterone production at the very top. It sits upstream of the entire HPG axis, triggering the natural cascade of GnRH → LH → testosterone, a different lever than the melanocortin libido peptides. Kisspeptin sits at the very top of the chain that produces testosterone.
Kisspeptin sits at the very top of the chain that produces testosterone. When you inject it, your body's own testosterone-making cascade fires off naturally. It's a different lever than PT-141, kisspeptin is upstream hormones, PT-141 is melanocortin pathway.
Modulates your own HPG axis rather than introducing exogenous testosterone, but federations differ.
FDA places kisspeptin-10 in Category 2 of the 503A nominations, one of only six substances in that category. Its concern is immunogenicity risk by certain routes, peptide-impurity and characterization complexity, and having no or only limited safety information for the proposed routes, which leaves FDA unable to say whether it would harm humans. Category 2 sits outside FDA's Category 1 interim policy, so FDA has said it would consider action under its general enforcement policies. It is not on the 503A bulks list.
Explicitly named on the 2026 WADA Prohibited List under S2.2.1 (testosterone-stimulating peptides), prohibited in male athletes at all times. Not restricted in female athletes.
Used in some fertility-medicine research contexts.
Who it's for
- →Users with low LH / suppressed HPG axis post-cycle
- →Fertility-adjacent contexts under medical guidance
- →Researchers exploring HPG-axis modulation
What to expect
- Week 1
LH and testosterone bumps within hours of dose. Subjective libido response varies.
- Week 4
If on a short course, complete it. Effects don't compound the way they do with daily peptides.
- Week 8
Off-cycle.
Looking at Kisspeptin-10? Your next 3 steps
- 1Work out your syringe units
Vial size + BAC water turns into the exact units to draw for Kisspeptin-10.
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account gets you Coach questions every day, free; membership saves your stack and makes the Coach stack-aware.
Create free account →
How it works (mechanism)
Activates the kisspeptin receptor (KISS1R / GPR54) on hypothalamic neurons. The most upstream signal in the HPG axis, kisspeptin tells the hypothalamus to release GnRH, which tells the pituitary to release LH/FSH, which drives gonadal testosterone production.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Pregnancy
- ⚠Active reproductive cancer
Bloodwork to monitor
- • LH, FSH, total testosterone if running for HPG-axis purposes
Common mistakes
- • Treating it like PT-141 (different mechanism, kisspeptin is upstream HPG, PT-141 is melanocortin)
- • Running it chronically
- • Stacking with multiple HPG modulators without monitoring
What it actually is
Kisspeptin-10 is a fragment of kisspeptin, the hormone that sits at the very top of the reproductive hormone cascade. It is the switch that starts puberty: without functioning kisspeptin signalling, the whole axis never turns on. It is a genuinely major piece of endocrinology with a large research literature — 34 randomised-trial records and 61 human-trial records indexed — most of it in fertility medicine rather than in the libido context people buy it for.
Kisspeptin neurons in the hypothalamus release kisspeptin onto GnRH neurons, which then release GnRH in pulses. GnRH tells the pituitary to release LH and FSH, which tell the testes or ovaries to make testosterone or oestrogen and gametes. Kisspeptin is therefore upstream of everything — a completely different lever from PT-141, which acts on desire pathways in the brain and does nothing to hormones. Kisspeptin-10 is cleared in about four minutes on intravenous dosing, which is why it produces a pulse rather than sustained stimulation. Subcutaneous pharmacokinetics are not established.
Forms, and which is which
Buyer reconstitutes. Research-chemical supply with unverified identity.
Verdict: The common route, unregulated.
Used in fertility medicine research, including as a trigger in IVF protocols where it carries a lower risk of ovarian hyperstimulation than conventional triggers.
Verdict: Where the real evidence sits.
A longer form used in some research protocols with different kinetics.
Verdict: A different molecule, not a stronger dose.
Worth being precise: HCG does not restart the axis, it substitutes for LH at the gonad and bypasses the suppressed upstream signal. SERMs act on the pituitary feedback. Both have real clinical use.
Verdict: The options with actual clinical evidence.
What it is claimed to do, graded
Thoroughly established physiology across a large human research literature. The magnitude depends on dose, route and where someone is in their cycle or axis state, so reliable describes the mechanism rather than a fixed response.
A real and promising research application — and the trigger evidence is largely for kisspeptin-54, a longer form, not the kisspeptin-10 sold under this name.
Demonstrated acutely in human studies, and the response depends on an intact axis below the hypothalamus. Whether repeated dosing produces a sustained rise is a different question and much less clear.
The reason most people in this space buy it. Some human imaging work suggests effects on sexual and emotional brain processing. It is not established as a libido treatment.
Continuous stimulation of a pulsatile system tends to desensitise it — the same principle GnRH agonists exploit to shut the axis DOWN in prostate cancer. Chronic use is unstudied and the theoretical risk runs in the wrong direction.
Grades describe how much human evidence exists for that specific claim, not whether it will work for you or whether it is safe.
Pros and cons
- • A genuinely major hormone with a large, high-quality human research literature
- • Acts upstream of the whole axis, so it works with the body's own pulsatile signalling
- • Very short half-life, so a mistake clears quickly
- • Well tolerated in the human research
- • The large literature is fertility endocrinology, not libido enhancement
- • Continuous dosing risks desensitising the very system it stimulates
- • Not approved for any use
- • Research-chemical supply with unverified identity
- • Effects on testosterone are acute and pulse-like, which is not what most buyers expect
When to stop
- • Any sign of hormone excess: acne flare, mood changes, breast tenderness
- • You have been running it continuously rather than in short courses
- • Testicular pain or swelling
- • Any new hormone-sensitive cancer diagnosis
Interactions
Directly opposing or overlapping action on the same axis.
Testosterone suppresses the axis kisspeptin stimulates. Working against each other.
Both aim to support the axis, at different points. No data on the combination.
Stimulating sex hormone production where a hormone-sensitive tumour may exist.
Not a drug interaction but the key practical risk: sustained stimulation of a pulsatile system can desensitise it.
Is this for you?
- • People interested in the axis physiology who understand the research is fertility medicine, not libido
- • Anyone using it in short courses rather than continuously
- • You are pregnant or trying to conceive without a fertility specialist involved
- • You have an active reproductive or hormone-sensitive cancer
- • You are on testosterone therapy — the two work against each other
- • You want a sustained testosterone increase; that is not what a four-minute pulse does
The one number
Sources for the claims above
- Role in control of the hypothalamic-pituitary-gonadal axis
- Kisspeptin and glucose homeostasis
- Kisspeptin in endometriosis
Drug & supplement interactions
- ⚠Hormone-modulating drugs (TRT, GnRH agonists/antagonists, oral contraceptives) all interact with the HPG axis kisspeptin sits at the top of
- ⚠Use under provider guidance if you're on any HPG-axis medication
New to Kisspeptin-10? Grab the starter checklist.
Drop your email and we'll send the one-page starter checklist beginners actually need first. No account needed.
No spam, and we never sell your email. Just the checklist. Email support@pepdex.co to opt out any time.
Numbers redacted in this preview. Members get the full answer, on their own stack.
Ask the Coach anything about Kisspeptin-10 or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Unlock the full Coach, from $4.99/week →Frequently asked
What is Kisspeptin-10?+
Is Kisspeptin-10 FDA approved?+
Is Kisspeptin-10 legal?+
Is Kisspeptin-10 banned by WADA?+
Are you still natty after taking Kisspeptin-10?+
Do doctors prescribe Kisspeptin-10?+
What's the typical dose of Kisspeptin-10?+
What are the side effects of Kisspeptin-10?+
How long until Kisspeptin-10 starts working?+
What can you stack with Kisspeptin-10?+
Where do people get Kisspeptin-10?+
Kisspeptin-10 vs PT-141 (Bremelanotide), which is better?+
Common questions about Kisspeptin-10
Head-to-head with Kisspeptin-10
Tracked alongside Kisspeptin-10
Same goal, different aisle — each graded on its own evidence in the Pepdex catalog.